These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 17495450

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy.
    Yan Y, Xu LX, Zhang JJ, Zhang Y, Zhao MH.
    Clin Exp Immunol; 2006 Apr; 144(1):17-24. PubMed ID: 16542360
    [Abstract] [Full Text] [Related]

  • 24. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.
    Schena FP, Pastore A, Ludovico N, Sinico RA, Benuzzi S, Montinaro V.
    Clin Exp Immunol; 1989 Jul; 77(1):15-20. PubMed ID: 2788538
    [Abstract] [Full Text] [Related]

  • 25. IgA nephropathy enigma.
    Mestecky J, Novak J, Moldoveanu Z, Raska M.
    Clin Immunol; 2016 Nov; 172():72-77. PubMed ID: 27444044
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.
    Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, Julian BA, Tomana M, Wyatt RJ, Edberg JC, Alarcón GS, Kimberly RP, Tomino Y, Mestecky J, Novak J.
    J Clin Invest; 2008 Feb; 118(2):629-39. PubMed ID: 18172551
    [Abstract] [Full Text] [Related]

  • 28. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
    Xu LX, Zhao MH.
    Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y.
    Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
    [Abstract] [Full Text] [Related]

  • 31. Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy.
    Lin X, Ding J, Zhu L, Shi S, Jiang L, Zhao M, Zhang H.
    Nephrol Dial Transplant; 2009 Nov; 24(11):3372-5. PubMed ID: 19531670
    [Abstract] [Full Text] [Related]

  • 32. Decreased IgA binding levels were accompanied by increased IgG sialylation in IgA nephropathy.
    Liu Y, Chen H, Li H, Wang F, Xing Y, Wu Z, Li W, Jia J, Yan T.
    Clin Nephrol; 2024 Aug; 102(2):89-96. PubMed ID: 38856027
    [Abstract] [Full Text] [Related]

  • 33. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
    Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J.
    Kidney Int; 2005 Feb; 67(2):504-13. PubMed ID: 15673298
    [Abstract] [Full Text] [Related]

  • 34. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.
    Novak J, Julian BA, Tomana M, Mestecky J.
    Semin Nephrol; 2008 Jan; 28(1):78-87. PubMed ID: 18222349
    [Abstract] [Full Text] [Related]

  • 35. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

  • 36. Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients.
    Kosztyu P, Hill M, Jemelkova J, Czernekova L, Kafkova LR, Hruby M, Matousovic K, Vondrak K, Zadrazil J, Sterzl I, Mestecky J, Raska M.
    Kidney Blood Press Res; 2018 Dec; 43(2):350-359. PubMed ID: 29529610
    [Abstract] [Full Text] [Related]

  • 37. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L, Peng L, Yang D, Chen S, Lan Z, Zhu X, Yuan S, Chen G, Liu Y, Liu H.
    Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
    [Abstract] [Full Text] [Related]

  • 38. O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.
    Novak J, King RG, Yother J, Renfrow MB, Green TJ.
    Glycobiology; 2024 Sep 30; 34(11):. PubMed ID: 39095059
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
    Xu LX, Yan Y, Zhang JJ, Zhang Y, Zhao MH.
    Clin Exp Immunol; 2005 Dec 30; 142(3):569-75. PubMed ID: 16297170
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.